| For: | Parsi S, Shirsat PD, Mahali LP, Surani S, Kashyap R. Sodium-glucose cotransporter 2 inhibitor in heart failure patients and their outcomes: A meta-analysis of randomized controlled trials. World J Cardiol 2025; 17(10): 109731 [PMID: 41181654 DOI: 10.4330/wjc.v17.i10.109731] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v17/i10/109731.htm |
| Number | Citing Articles |
| 1 |
Saketh Parsi, Kunal Sonavane, Usha Ravi, Pallavi D. Shirsat, Venkata S. Chamarthi, Mohamed Gabr, Harikrishna Choudary Ponnam, Salim Surani, Vikas Bansal, Rahul Kashyap. Effects of Sodium Glucose Co-Transporter 2 Inhibitors on Atrial Fibrillation Recurrences After Catheter Ablation in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2025; 14(22) doi: 10.3390/jcm14228001
|
| 2 |
Yi-Fei Zhang, Wu-Xiao Yang, Xue-Wen Li. Letter to the Editor: Ca<sup>2+</sup>/calmodulin-dependent protein kinase II in heart failure and the role of sodium-glucose-cotransporter 2 inhibitors. World Journal of Cardiology 2026; 18(4): 116558 doi: 10.4330/wjc.v18.i4.116558
|
| 3 |
Minkwan Kim, Seok-Jae Heo, SungA Bae, In Hyun Jung, Deok-Kyu Cho. Effectiveness of low-dose SGLT2 inhibitors in diabetic patients with heart failure: a nationwide cohort study. Frontiers in Cardiovascular Medicine 2026; 13 doi: 10.3389/fcvm.2026.1859003
|
| 4 |
Abdullah Sameer Alshammari, Foud O. Bahamdain, Asma M. Alshahrani, Geetha Kandasamy, Ageeli Rabea Mussa Rabea, Wid Alyamani, Anas Idris, Yara Kamfar, Maher Almalki, Saleh Alghamdi, Mohammed Kanan, Nisrin Bifari, Shaimaa Alsulami, Abdulmalik S. Alotaibi, Emad Elkholy. Patterns of spironolactone management following hyperkalemia among hospitalized patients with heart failure and reduced ejection fraction: a retrospective single-center study. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1870470
|